RxDoctor Payments Data

Walter Hutchings, MD

Family Medicine · Macon, GANPI 1952460255

Payments from drug & device makers

$3,553in general payments, 2019–2025

Across 115 payments — averaging $30.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$846
  • Pfizer$263
  • Johnson & Johnson$173
  • Boehringer Ingelheim$137
  • Viiv Healthcare Company$90
  • plus $732 from 19 others

What the payments were for

  • Food & beverage$3,553100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,553 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$26,479
Medicare patients
170
Services billed
287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide48$48,269
JardianceEmpagliflozin19$33,244
EliquisApixaban25$29,811
XareltoRivaroxaban18$18,943
FarxigaDapagliflozin Propanediol14$12,999
TrulicityDulaglutide12$11,496
Advair HfaFluticasone Propion/Salmeterol13$4,987
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen116$3,096
Albuterol Sulfate HfaAlbuterol Sulfate51$2,216
Pravastatin Sodium216$1,951
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen36$1,377
Fluticasone Propionate77$1,329
Azelastine Hcl13$1,283
Metformin Hcl180$1,253
Gabapentin71$1,185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$846$48,26948 claims
Boehringer IngelheimJardiance$137$33,24419 claims
PfizerEliquis$263$29,81125 claims
Johnson & JohnsonXarelto$173$18,94318 claims
AstraZenecaFarxiga$1,311$12,99914 claims
Lilly USA, LLCTrulicity$48$11,49612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →